Boston Scientific Corp. (NYSE: BSX) reported Q4 EPS of $0.13, $0.05 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.91 billion.

Boston Scientific Corp. sees Q1 2012 revenue of $1.83-$1.9 million, versus the consensus of $1.9 million.

For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.

Earnings Guidance